JP2020508994A5 - - Google Patents

Download PDF

Info

Publication number
JP2020508994A5
JP2020508994A5 JP2019544865A JP2019544865A JP2020508994A5 JP 2020508994 A5 JP2020508994 A5 JP 2020508994A5 JP 2019544865 A JP2019544865 A JP 2019544865A JP 2019544865 A JP2019544865 A JP 2019544865A JP 2020508994 A5 JP2020508994 A5 JP 2020508994A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
alcohol
group
motomeko
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019544865A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020508994A (ja
JP7012089B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2018/050044 external-priority patent/WO2018148785A1/en
Publication of JP2020508994A publication Critical patent/JP2020508994A/ja
Publication of JP2020508994A5 publication Critical patent/JP2020508994A5/ja
Priority to JP2022005183A priority Critical patent/JP2022050641A/ja
Application granted granted Critical
Publication of JP7012089B2 publication Critical patent/JP7012089B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019544865A 2017-02-15 2018-01-24 皮膚炎および炎症性皮膚疾患の処置のためのカンナビノイドの製剤 Expired - Fee Related JP7012089B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022005183A JP2022050641A (ja) 2017-02-15 2022-01-17 皮膚炎および炎症性皮膚疾患の処置のためのカンナビノイドの製剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762459363P 2017-02-15 2017-02-15
AU2017900495A AU2017900495A0 (en) 2017-02-15 Formulations of Cannabinoids for the Treatment of Dermatitis and Inflammatory Skin Diseases
AU2017900495 2017-02-15
US62/459,363 2017-02-15
PCT/AU2018/050044 WO2018148785A1 (en) 2017-02-15 2018-01-24 Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022005183A Division JP2022050641A (ja) 2017-02-15 2022-01-17 皮膚炎および炎症性皮膚疾患の処置のためのカンナビノイドの製剤

Publications (3)

Publication Number Publication Date
JP2020508994A JP2020508994A (ja) 2020-03-26
JP2020508994A5 true JP2020508994A5 (cg-RX-API-DMAC7.html) 2020-12-17
JP7012089B2 JP7012089B2 (ja) 2022-01-27

Family

ID=67766794

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019544865A Expired - Fee Related JP7012089B2 (ja) 2017-02-15 2018-01-24 皮膚炎および炎症性皮膚疾患の処置のためのカンナビノイドの製剤
JP2022005183A Withdrawn JP2022050641A (ja) 2017-02-15 2022-01-17 皮膚炎および炎症性皮膚疾患の処置のためのカンナビノイドの製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022005183A Withdrawn JP2022050641A (ja) 2017-02-15 2022-01-17 皮膚炎および炎症性皮膚疾患の処置のためのカンナビノイドの製剤

Country Status (8)

Country Link
US (1) US20210401768A1 (cg-RX-API-DMAC7.html)
EP (1) EP3582768A4 (cg-RX-API-DMAC7.html)
JP (2) JP7012089B2 (cg-RX-API-DMAC7.html)
CN (1) CN110545807B (cg-RX-API-DMAC7.html)
AU (1) AU2018221880B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019017018A2 (cg-RX-API-DMAC7.html)
CA (1) CA3053500A1 (cg-RX-API-DMAC7.html)
IL (1) IL268720B2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220323401A1 (en) * 2017-02-15 2022-10-13 Botanix Pharmaceuticals Ltd. Formulations of cannabinoids for the treatment of acne
BR112020014911A2 (pt) 2018-01-24 2020-12-08 Botanix Pharmaceuticals Ltd Regime de dosagem de canabinoide para dermatite e condições de pele inflamatórias
CN111000740A (zh) * 2020-01-07 2020-04-14 杭州百芮生物科技有限公司 一种添加大麻提取成分组合物、制备方法及其应用
CN111514280A (zh) * 2020-06-15 2020-08-11 中国人民解放军西部战区总医院 一种预防放射性皮炎的药物
CN111671885A (zh) * 2020-06-15 2020-09-18 中国人民解放军西部战区总医院 一种用于治疗放射性皮炎的药物
CN113479456A (zh) * 2021-04-06 2021-10-08 上海思乐得不锈钢制品有限公司 一种用于储运生物制品的真空容器
US20230039887A1 (en) * 2021-07-20 2023-02-09 Enveric Biosciences, Inc. Compositions for topical treatment of radiation dermatitis
US12059393B2 (en) 2022-02-11 2024-08-13 Akos Biosciences, Inc. Compositions for topical treatment of radiation dermatitis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0104268D0 (en) * 2001-02-21 2001-04-11 Unilever Plc Antiperspirant or deodorant compositions
DE60228713D1 (de) * 2001-07-18 2008-10-16 Unilever Nv Zusammensetzungen für die behandlung von haaren und/oder kopfhaut
WO2008024408A2 (en) * 2006-08-22 2008-02-28 Theraquest Biosciences, Inc. Pharmaceutical formulations of cannabinoids for application to the skin and method of use
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent
ES2541485T3 (es) * 2010-10-19 2015-07-21 Parenteral, A.S. Composición para el tratamiento de enfermedades inflamatorias, la cual comprende ácidos boswéllicos y cannabidiol
GB201019240D0 (en) * 2010-11-15 2010-12-29 Vib Vzw Respiratory syncytical virus vaccine
US20130184354A1 (en) 2012-01-13 2013-07-18 Donna K. Jackson Silicone and Hylauronic Acid (HLA) Delivery Systems for Products by Sustainable Processes for Medical Uses Including Wound Management
EP2664327A1 (en) 2012-05-14 2013-11-20 Almirall S.A. Topical pharmaceutical compositions comprising terbinafide and urea
CA2890333C (en) * 2012-11-06 2021-03-23 Rochal Industries, Llc Delivery of biologically-active agents using volatile, hydrophobic solvents
US20160022627A2 (en) * 2014-04-18 2016-01-28 Mary's Medicinals LLC Transdermal cannabinoid patch
JP2018507262A (ja) 2015-03-02 2018-03-15 アフギン ファーマ, エルエルシーAfgin Pharma, Llc カンナビノイドを用いた、局所局部的神経作用療法
US20160374958A1 (en) * 2015-06-23 2016-12-29 Axim Biotechnologies, Inc. Anti-microbial composition comprising cannabinoids

Similar Documents

Publication Publication Date Title
JP2020508994A5 (cg-RX-API-DMAC7.html)
JP2020508992A5 (cg-RX-API-DMAC7.html)
JP5938497B2 (ja) 抗真菌医薬組成物
JP5988406B2 (ja) 起泡性組成物
NZ597335A (en) Silicone scar treatment preparation
WO2008097851A1 (en) Tetracycline compositions for topical administration
CN101795669A (zh) 用于递送药物的组合物
US20160106659A1 (en) Polysilicone base for scar treatment
EP3689328A1 (en) Compositions for relieving pain comprising malkangni oil and cypriol oil as active ingredients
JP2014001206A (ja) ヘア及びボディ用オイル
JP2014518272A5 (cg-RX-API-DMAC7.html)
RU2006137291A (ru) Безводная фармацевтическая композиция, включающая силиконовый агент и растворимый активный компонент
CN113164351A (zh) 非铝止汗剂组合物
US2457188A (en) Benzocaine solution
JP2020508993A5 (cg-RX-API-DMAC7.html)
KR20070027587A (ko) 실리콘제, 코르티코스테로이드 및 비타민 ｄ 또는 이의유도체를 함유하는 건선 치료용 조성물
JP2008542423A (ja) 皮膚を通しての薬物の制御放出方法
EP2498770B1 (en) Pharmaceutical composition
JP7069176B2 (ja) 医薬組成物
JP2019011261A (ja) 外用組成物
CN102144952B (zh) 一种化妆品用w/o乳化剂的制备方法和应用
JP7301536B2 (ja) 外用組成物
CN118475340A (zh) 用于护理角蛋白材料的油的组合物
JP6284463B2 (ja) 乳化シェービング剤
WO2025010400A3 (en) Compositions and methods for improved treatment of skin wounds